Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients

This study aimed to investigate the correlation between complement C1q tumor necrosis factor-related protein 1 (CTRP1) and subclinical target organ damage (STOD) in essential hypertension (EH). 720 patients were enrolled in this study, including 360 healthy subjects and 360 patients with EH. The EH...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengjia Su, Shuya Tian, Wei Liang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Cardiovascular Therapeutics
Online Access:http://dx.doi.org/10.1155/2019/4183781
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550358558179328
author Zhengjia Su
Shuya Tian
Wei Liang
author_facet Zhengjia Su
Shuya Tian
Wei Liang
author_sort Zhengjia Su
collection DOAJ
description This study aimed to investigate the correlation between complement C1q tumor necrosis factor-related protein 1 (CTRP1) and subclinical target organ damage (STOD) in essential hypertension (EH). 720 patients were enrolled in this study, including 360 healthy subjects and 360 patients with EH. The EH group included 183 patients complicated with STOD and 177 patients without STOD. In the STOD group, there were 87 patients with left ventricular hypertrophy (LVH), 32 patients with microalbuminuria (MAU), and 58 patients with complication of LVH and MAU. Enzyme-linked immunosorbent assay (ELISA) was used to detect the CTRP1, adiponectin (APN), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). We found that CTRP1 levels were higher in patients with EH than those in healthy subjects; moreover, the level of CTRP1 of patients in the group complicated with EH and STOD was increased compared with EH patients without STOD. CTRP1 levels in the group complicated with LVH and MAU were significantly higher than those in the LVH group and the MAU group. Furthermore, APN, CTRP1, and IL-6 were three factors that influenced the STOD of EH patients, among which CTRP1 and IL6 were positively related with the complication of hypertension and STOD. In conclusion, CTRP1 levels are increased and associated with the STOD (heart and kidney) in essential hypertension, which can be regarded as a novel biomarker in the prediction of prognosis for patients with essential hypertension.
format Article
id doaj-art-7234b20d260645d6911ac2d6a2c27058
institution Kabale University
issn 1755-5914
1755-5922
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Cardiovascular Therapeutics
spelling doaj-art-7234b20d260645d6911ac2d6a2c270582025-02-03T06:06:57ZengWileyCardiovascular Therapeutics1755-59141755-59222019-01-01201910.1155/2019/41837814183781Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese PatientsZhengjia Su0Shuya Tian1Wei Liang2Department of Geratology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Geratology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaDepartment of Geratology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaThis study aimed to investigate the correlation between complement C1q tumor necrosis factor-related protein 1 (CTRP1) and subclinical target organ damage (STOD) in essential hypertension (EH). 720 patients were enrolled in this study, including 360 healthy subjects and 360 patients with EH. The EH group included 183 patients complicated with STOD and 177 patients without STOD. In the STOD group, there were 87 patients with left ventricular hypertrophy (LVH), 32 patients with microalbuminuria (MAU), and 58 patients with complication of LVH and MAU. Enzyme-linked immunosorbent assay (ELISA) was used to detect the CTRP1, adiponectin (APN), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). We found that CTRP1 levels were higher in patients with EH than those in healthy subjects; moreover, the level of CTRP1 of patients in the group complicated with EH and STOD was increased compared with EH patients without STOD. CTRP1 levels in the group complicated with LVH and MAU were significantly higher than those in the LVH group and the MAU group. Furthermore, APN, CTRP1, and IL-6 were three factors that influenced the STOD of EH patients, among which CTRP1 and IL6 were positively related with the complication of hypertension and STOD. In conclusion, CTRP1 levels are increased and associated with the STOD (heart and kidney) in essential hypertension, which can be regarded as a novel biomarker in the prediction of prognosis for patients with essential hypertension.http://dx.doi.org/10.1155/2019/4183781
spellingShingle Zhengjia Su
Shuya Tian
Wei Liang
Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients
Cardiovascular Therapeutics
title Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients
title_full Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients
title_fullStr Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients
title_full_unstemmed Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients
title_short Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients
title_sort circulating ctrp1 levels are increased and associated with the stod in essential hypertension in chinese patients
url http://dx.doi.org/10.1155/2019/4183781
work_keys_str_mv AT zhengjiasu circulatingctrp1levelsareincreasedandassociatedwiththestodinessentialhypertensioninchinesepatients
AT shuyatian circulatingctrp1levelsareincreasedandassociatedwiththestodinessentialhypertensioninchinesepatients
AT weiliang circulatingctrp1levelsareincreasedandassociatedwiththestodinessentialhypertensioninchinesepatients